Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$4.29 USD
+0.08 (1.90%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $4.24 -0.05 (-1.17%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
[BOLD]
Reports for Purchase
Showing records 21 - 40 ( 89 total )
Industry: Medical - Biomedical and Genetics
AT-132 Registration Strategy Complemented by Progress on Next Value Drivers Mark 1H19
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
1Q19 Financials; New Look Neuromuscular Company Looking Good in 2019
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Big End of Year in Store; Pipeline Pivot to Neuromuscular Diseases Widely Anticipated
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Combination of Surrogate and Clinical Endpoints Position AMT132 for a 2020 Approval
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Another Impressive MTM Update, Discussions with Regulators up Next in Q3:19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Vectorized ASO''s for DMD; a Trip Down Memory Lane; Raising Target to $48
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Vectorized ASO''s for DMD; a Trip Down Memory Lane; Raising Target to $48
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Keeping an Eye Out for Pompe and Expansion Into a New Neuromuscular Indication; Raising Target to $44
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
No Fireworks yet; However, 2H19 Looks More Promising
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
FY18 Financials; Important MTM Cohort Two Data Ahead at ASGCT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Biomedical and Genetics
As Expected, BOLD to Enroll Additional ASPIRO Patients, Data Update at ASGCT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
AT132 Accelerated Approval During 2020 Is Well Within the Realm of Possibilities
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
3Q18 Corporate Update: One Big Step Forward, Two Small Steps Back
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D